First Allied Advisory Services’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | $2.6M | Sell |
9,535
-341
| -3% | -$94.1K | 0.09% | 241 |
|
|
2020
Q2 | $2.87M | Buy |
9,876
+3,736
| +61% | +$1.01M | 0.11% | 203 |
|
|
2020
Q1 | $1.46M | Buy |
6,140
+789
| +15% | +$181K | 0.06% | 310 |
|
|
2019
Q4 | $1.18M | Buy |
5,351
+653
| +14% | +$132K | 0.04% | 424 |
|
|
2019
Q3 | $800K | Buy |
4,698
+691
| +17% | +$122K | 0.03% | 531 |
|
|
2019
Q2 | $735K | Buy |
4,007
+755
| +23% | +$132K | 0.03% | 551 |
|
|
2019
Q1 | $593K | Sell |
3,252
-244
| -7% | -$45.1K | 0.02% | 620 |
|
|
2018
Q4 | $572K | Sell |
3,496
-600
| -15% | -$104K | 0.02% | 573 |
|
|
2018
Q3 | $793K | Buy |
4,096
+1,922
| +88% | +$342K | 0.03% | 550 |
|
|
2018
Q2 | $372K | Buy |
2,174
+204
| +10% | +$31.6K | 0.01% | 792 |
|
|
2018
Q1 | $318K | Sell |
1,970
-15
| -0.8% | -$2.45K | 0.01% | 842 |
|
|
2017
Q4 | $296K | Sell |
1,985
-286
| -13% | -$42.3K | 0.01% | 881 |
|
|
2017
Q3 | $345K | Sell |
2,271
-183
| -7% | -$27.5K | 0.01% | 757 |
|
|
2017
Q2 | $315K | Sell |
2,454
-169
| -6% | -$20.3K | 0.01% | 803 |
|
|
2017
Q1 | $287K | Buy |
+2,623
| New | +$231K | 0.01% | 805 |
|
|
2016
Q4 | – | Sell |
-2,547
| Closed | -$222K | – | 1171 |
|
|
2016
Q3 | $222K | Sell |
2,547
-6,393
| -72% | -$604K | 0.01% | 892 |
|
|
2016
Q2 | $774K | Sell |
8,940
-1,931
| -18% | -$167K | 0.04% | 423 |
|
|
2016
Q1 | $872K | Buy |
10,871
+8,266
| +317% | +$748K | 0.05% | 393 |
|
|
2015
Q4 | $329K | Buy |
2,605
+88
| +3% | +$10.6K | 0.02% | 740 |
|
|
2015
Q3 | $265K | Sell |
2,517
-543
| -18% | -$69.8K | 0.01% | 805 |
|
|
2015
Q2 | $379K | Buy |
3,060
+509
| +20% | +$64.1K | 0.02% | 731 |
|
|
2015
Q1 | $304K | Sell |
2,551
-1,169
| -31% | -$140K | 0.02% | 772 |
|
|
2014
Q4 | $444K | Buy |
+3,720
| New | +$419K | 0.03% | 572 |
|
Other funds holding VRTX
